Disc Medicine, Inc. (IRON)
NASDAQ: IRON · Real-Time Price · USD
48.62
-3.74 (-7.14%)
Mar 31, 2025, 1:31 PM EDT - Market open
Disc Medicine Employees
Disc Medicine had 84 employees as of December 31, 2024. The number of employees increased by 10 or 13.51% compared to the previous year.
Employees
84
Change (1Y)
10
Growth (1Y)
13.51%
Revenue / Employee
n/a
Profits / Employee
-$1,301,869
Market Cap
1.68B
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 84 | 10 | 13.51% |
| Dec 31, 2023 | 74 | 28 | 60.87% |
| Dec 31, 2022 | 46 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
IRON News
- 4 weeks ago - Disc Medicine Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Update - GlobeNewsWire
- 4 weeks ago - Disc Medicine to Participate in Upcoming Investor Conferences - GlobeNewsWire
- 2 months ago - Disc Medicine Announces Pricing of $225.5 Million Upsized Public Offering of Common Stock and Pre-Funded Warrants - GlobeNewsWire
- 2 months ago - Progress Software, Disc Medicine And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session - Benzinga
- 2 months ago - Disc Medicine Announces Proposed Public Offering of Common Stock and Pre-Funded Warrants - GlobeNewsWire
- 2 months ago - Disc Medicine Announces Successful Type C Meeting with FDA for Bitopertin in Erythropoietic Protoporphyria (EPP) and Shares Plans for NDA Submission - GlobeNewsWire
- 2 months ago - Disc Medicine to Host Conference Call on Type C Meeting for Bitopertin in Erythropoietic Protoporphyria (EPP) - GlobeNewsWire
- 2 months ago - Disc Medicine Reports Inducement Grant under Nasdaq Listing Rule 5635(C)(4) - GlobeNewsWire